Data lead to answers.
Fundamental to public health research and policy, biostatistics is also one of the most interdisciplinary departments at Boston University School of Public Health. By designing studies, developing new methodologies, and extracting and analyzing information from data, we help inform decisions to promote better health.
Biostatistics faculty members are internationally recognized for methodological innovations in clinical trials and observational studies, statistical genetics analysis, and Bayesian methods. They have a long history of collaborating to address some of the world’s most pressing public health concerns, as well as training the next generation of students to tackle emerging public health and medical issues with cutting-edge methods and technological skills.
Areas in which we are active include genetic studies of risk factors for breast cancer; safety and efficacy assessments of a new Alzheimer’s disease drug; comparisons of patient outcomes with different behavioral interventions; and studies to identify genetic and non-genetic factors of healthy aging and extreme human longevity.
Affiliated Academic Programs:
Recent Department News
Latest Publications
- Published On 6/1/2025Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial.JAMA internal medicineread at PubMed
- Published On 6/1/2025Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019.American journal of respiratory and critical care medicineread at PubMed
- Published On 5/28/2025Mean Corpuscular Hemoglobin Modulates HbF/F-Cell and Clinical Response to Gene Therapy and Hydroxyurea in Sickle Cell Disease.American journal of hematologyread at PubMed
- Published On 5/26/2025Lipoprotein(a) and Heart Failure Among Black and White Participants in Atherosclerosis Risk in Communities Study, Framingham Offspring Study, and Multi-Ethnic Study of Atherosclerosis: The Pooling Project.Journal of the American Heart Associationread at PubMed
- Published On 5/26/2025Operational Development and Launch of an Adaptive Platform Trial in Amyotrophic Lateral Sclerosis: Processes and Learnings From the First Four Regimens of the HEALEY ALS Platform Trial.Muscle & nerveread at PubMed